What is Solid Biosciences Inc.'s capex?

Solid Biosciences Inc. (SLDB) reported capex of $165K in Q1 2026.

How has Solid Biosciences Inc.'s capex changed year-over-year?

Solid Biosciences Inc.'s capex increased by 31.0% year-over-year, from $126K to $165K.

What is the long-term trend for Solid Biosciences Inc.'s capex?

Over 4 years (2021 to 2025), Solid Biosciences Inc.'s capex has grown at a -2.6% compound annual growth rate (CAGR), from $1.28M to $1.15M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Solid Biosciences Inc. SLDB CapEx

CapEx at other companies

Sarepta Therapeutics, Inc.SRPT

$2.08M-95.2%

BiogenBIIB

$51.2M+38.0%

Neurocrine BiosciencesNBIX

$9.1M-15.0%

InsmedINSM

$3.48M-65.4%

Dyne Therapeutics, Inc.DYN

$221K-77.5%

Taysha Gene Therapies, Inc.TSHA

$24K-93.7%

Other financials

Income statement

See full

Revenue$2.0M-40.6%

Operating income-$57.3M-43.1%

Net income-$56.7M-44.4%

EPS (diluted)-$0.52+11.9%

Balance sheet

See full

Cash & equivalents$297.1M+41.1%

Total debt$20.7M-12.5%

Total equity$374.1M+27.1%

Total assets$422.9M+23.0%

Cash flow

See full

Operating cash flow-$47.2M-48.3%

Free cash flow-$47.4M-48.2%

Valuation

See full

Market cap$910.66M+145%

Enterprise value$634.23M+244%

P/S112.5×-10.3×

Profitability

See full

Operating margin-1,315.2%-4,060pp

Net margin-1,062.3%-251,151pp

FCF margin-1,247.7%-9,569pp

Returns & leverage

See full

Return on equity-57.4%+2.2pp

Debt / equity0.1×0.0×

Current ratio13.1×+2.2×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solid Biosciences Inc.'s capex?: Solid Biosciences Inc. (SLDB) reported capex of $165K in Q1 2026.
How has Solid Biosciences Inc.'s capex changed year-over-year?: Solid Biosciences Inc.'s capex increased by 31.0% year-over-year, from $126K to $165K.
What is the long-term trend for Solid Biosciences Inc.'s capex?: Over 4 years (2021 to 2025), Solid Biosciences Inc.'s capex has grown at a -2.6% compound annual growth rate (CAGR), from $1.28M to $1.15M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.